C22orf25 Polyclonal Antibody, Cy3 Conjugated
- Size: 100ul
- Application: IF(IHC-P)
- Reactivity: Human, Mouse, Rat
- Predicted Reactivity:
-
Datasheet
Tech Support
PRODUCT DETAILS
SPECIFICATIONS |
|
|---|---|
|
PRODUCT NAME |
C22orf25 Polyclonal Antibody, Cy3 Conjugated |
|
CONJUGATION |
Cy3 |
|
HOST |
Rabbit |
| SOURCE |
KLH conjugated synthetic peptide derived from human C22orf25 |
| IMMUNOGEN RANGE |
25-75/276 |
| CLONALITY |
Polyclonal |
| ISOTYPE |
IgG |
| CONCENTRATION |
1ug/ul |
| PURIFICATION |
Purified by Protein A. |
| STORAGE BUFFER |
Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. |
| STORAGE CONDITION |
Store at 4°C for 12 months. |
TARGET |
|
|---|---|
| GENE ID |
|
| SUBCELLULAR LOCATION |
|
| SYNONYMS |
Uncharacterized protein C22orf25; chromosome 22 open reading frame 25; DKFZp 761 P 1121; Hypothetical protein LOC128989; TNG2_HUMAN; TANGO2; Transport and Golgi organization protein 2 homolog. |
| BACKGROUND |
Chromosome 22 contains over 500 genes and about 49 million bases. Being the second smallest human chromosome, 22 contains a surprising variety of interesting genes. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia. The C22orf25 gene product has been provisionally designated C22orf25 pending further characterization. |
| APPLICATION DILUTION |
IF(IHC-P)(1:50-200) |